---
title: "STTK: Lead DR3 antibody SL-325 shows promise for IBD with strong safety and low immunogenicity"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292627952.md"
description: "Pioneering DR3-targeted antibodies, the pipeline aims to address unmet needs in IBD and other immune diseases. Lead candidate SL-325 showed strong safety, durable efficacy, and low immunogenicity in Phase 1, with a Phase 2b Crohn's trial set for Q3 2026. Cash reserves support operations into 2029.Original document: Shattuck Labs, Inc. [STTK] Slides Release — Jul. 14 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-07-14T12:45:10.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292627952.md)
  - [en](https://longbridge.com/en/news/292627952.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292627952.md)
---

# STTK: Lead DR3 antibody SL-325 shows promise for IBD with strong safety and low immunogenicity

Pioneering DR3-targeted antibodies, the pipeline aims to address unmet needs in IBD and other immune diseases. Lead candidate SL-325 showed strong safety, durable efficacy, and low immunogenicity in Phase 1, with a Phase 2b Crohn's trial set for Q3 2026. Cash reserves support operations into 2029.

Original document: Shattuck Labs, Inc. \[STTK\] Slides Release — Jul. 14 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [STTK.US](https://longbridge.com/en/quote/STTK.US.md)

## Related News & Research

- [Shattuck Labs (NASDAQ:STTK) Coverage Initiated by Analysts at JPMorgan Chase & Co.](https://longbridge.com/en/news/293754515.md)
- [Shattuck Labs posts corporate presentation outlining DR3 antibody program for inflammatory diseases](https://longbridge.com/en/news/292628624.md)
- [The AI memory boom just got a reality check—and a better entry point](https://longbridge.com/en/news/294587185.md)
- [AI stocks vs. space stocks: Which is the better long-term investment?](https://longbridge.com/en/news/294586486.md)
- [Palantir’s next leap - why its stock keeps surprising investors](https://longbridge.com/en/news/294605106.md)